24 May 2013
Keywords: elidel, works, adult, eczema, patients, results, phase
Article | 04 March 2002
Results of a Phase III trial of Novartis' recently-approvednon-steroidal treatment for atopic eczema, Elidel (pimecrolimus),
suggest that the drug can ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 March 2002
23 May 2013
© 2013 thepharmaletter.com